Who owns Telomir Pharmaceuticals, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Telomir Pharmaceuticals, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
• Leadership changes: the latest reported is Andriy Mushak, Chief Financial Officer (Form 8-K filed 2026-06-08). Check you are dealing with the people now in charge.
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names John Paul Dejoria, As Trustee Of The John Paul Dejoria Family Trust, And In His Individual Capacity (filed 2026-08-14).

Who is behind it

Telomir Pharmaceuticals, Inc.: incorporated in Florida; business address in Miami, Florida; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).

Officers and directors, each with the role and the filing that names them:

• Chris Chapman: Executive Officer, Director (Form D, 2023-04-03)
• James McNulty: Executive Officer (Form D, 2023-04-03)
• Jude Uzonwanne: Director (Form D, 2023-04-03)
• David Vorhoff: Director (Form D, 2023-04-03)
• Hugh McColl: Director (Form D, 2023-04-03)
• Craig Eagle: Director (Form D, 2023-04-03)
• Tuck Talhia: Director (Form D, 2023-04-03)

Money raised

Acquisitions reported on Form 8-K, Item 2.01: acquired TELI Pharmaceuticals, Inc. (2026-04-24).

Related pages

Leadership changes5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.